Lion Point Capital’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-39,589
| Closed | -$153K | – | 24 |
|
|
2024
Q3 | $153K | Sell |
39,589
-51,205
| -56% | -$198K | 0.34% | 20 |
|
|
2024
Q2 | $211K | Hold |
90,794
| – | – | 0.38% | 19 |
|
|
2024
Q1 | $256K | Hold |
90,794
| – | – | 0.14% | 22 |
|
|
2023
Q4 | $289K | Hold |
90,794
| – | – | 0.14% | 22 |
|
|
2023
Q3 | $300K | Buy |
90,794
+12,443
| +16% | +$41.1K | 0.13% | 24 |
|
|
2023
Q2 | $259K | Buy |
78,351
+27,146
| +53% | +$89.6K | 0.12% | 23 |
|
|
2023
Q1 | $169K | Hold |
51,205
| – | – | 0.07% | 25 |
|
|
2022
Q4 | $732K | Hold |
51,205
| – | – | 0.1% | 21 |
|
|
2022
Q3 | $732K | Hold |
51,205
| – | – | 0.16% | 24 |
|
|
2022
Q2 | $732K | Hold |
51,205
| – | – | 0.08% | 29 |
|
|
2022
Q1 | $481K | Hold |
51,205
| – | – | 0.11% | 27 |
|
|
2021
Q4 | $354K | Sell |
51,205
-355,987
| -87% | -$2.46M | 0.09% | 25 |
|
|
2021
Q3 | $3.87M | Hold |
407,192
| – | – | 0.73% | 20 |
|
|
2021
Q2 | $4.07M | Hold |
407,192
| – | – | 0.7% | 21 |
|
|
2021
Q1 | $4.76M | Hold |
407,192
| – | – | 0.87% | 18 |
|
|
2020
Q4 | $14.5M | Hold |
407,192
| – | – | 2.8% | 11 |
|
|
2020
Q3 | $5.63M | Hold |
407,192
| – | – | 1.23% | 15 |
|
|
2020
Q2 | $6.71M | Hold |
407,192
| – | – | 1.63% | 15 |
|
|
2020
Q1 | $3.46M | Buy |
407,192
+61,111
| +18% | +$519K | 0.91% | 17 |
|
|
2019
Q4 | $7.88M | Buy |
+346,081
| New | +$7.88M | 0.73% | 17 |
|